Current clinical evidence and meta-analyses demonstrate that aspirin does not need to be routinely restricted or discontinued prior to cataract surgery, as it does not increase the risk of serious hemorrhagic complications.
The claim states that aspirin-based medications are restricted before and after cataract surgery. The retrieved literature directly addresses this and refutes the claim. Multiple recent studies and a large meta-analysis ([7], [2], [1]) indicate that aspirin can be safely continued during cataract surgery without increasing sight-threatening bleeding risks, and that routine cessation is generally unnecessary.